NEW YORK--(BUSINESS WIRE)-- Press Kit Materials are Available at: http://www.tradeshownews.com/events/Rodman-Renshaw-Annual-Global-Investment-Conference-NYC/ziopharm/
|Event:||Rodman & Renshaw Annual Global Investment Conference NYC
Sep 13 - 15, 2010
New York, NY, US
About Ziopharm Oncology
ZIOPHARM Oncology, Inc. is a biopharmaceutical company that is seeking to develop and commercialize a diverse, portfolio of cancer drugs. Our principal focus is on the development of proprietary small molecule drug candidates that work on validated targets. The goal is to develop intravenous ("IV") and/or oral forms of administration. We believe this strategy will result in lower-risk and lower-cost development programs with product candidates having a low cost of manufacturing to address changing reimbursement requirements around the world.
KEYWORDS: United States North America New York
INDUSTRY KEYWORDS: Health Biotechnology Oncology Pharmaceutical Other Health Research Science